Device And Method For Immobilizing Patients For Breast Radiation Therapy

  *US09084886B2*
  US009084886B2                                 
(12)United States Patent(10)Patent No.: US 9,084,886 B2
  et al. (45) Date of Patent:*Jul.  21, 2015

(54)Device and method for immobilizing patients for breast radiation therapy 
    
(75)Inventor: Loma Linda University Medical Center,  Loma Linda, CA (US) 
(73)Assignee:Loma Linda University Medical Center,  Loma Linda, CA (US), Type: US Company 
(*)Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. 
  This patent is subject to a terminal disclaimer. 
(21)Appl. No.: 14/015,002 
(22)Filed: Aug.  30, 2013 
(65)Prior Publication Data 
 US 2014/0217634 A1 Aug.  7, 2014 
 Related U.S. Patent Documents 
(63) .
Continuation of application No. 13/540,475, filed on Jul.  2, 2012, now Pat. No. 8,523,630 , which is a continuation of application No. 12/515,523, now Pat. No. 8,210,899 .
 
(60)Provisional application No. 60/866,814, filed on Nov.  21, 2006.
 
Jan.  1, 2013 A 61 N 5 10 F I Jul.  21, 2015 US B H C Jan.  1, 2013 A 41 C 3 00 L I Jul.  21, 2015 US B H C Jan.  1, 2013 A 61 B 6 0435 L I Jul.  21, 2015 US B H C Jan.  1, 2013 A 61 N 5 1049 L I Jul.  21, 2015 US B H C Jan.  1, 2013 A 61 N 2005 1097 L A Jul.  21, 2015 US B H C
(51)Int. Cl. A41C 003/00 (20060101); A61N 005/10 (20060101); A61B 006/04 (20060101)
(58)Field of Search  450/92, 93, 1, 39, 54-58, 36-38; 600/562-567, 411, 414, 417, 426, 427, 429, 439

 
(56)References Cited
 
 U.S. PATENT DOCUMENTS
 2,469,084  A  5/1949    Schenker     
 2,580,264  A*12/1951    Wright et al. 623/7
 2,675,564  A  4/1954    Hughes     
 3,145,240  A*8/1964    Proulx et al. 264/53
 3,397,411  A  8/1968    Rossi     
 3,449,570  A  6/1969    Kok     
 3,545,739  A  12/1970    D'Avignon     
 3,556,455  A  1/1971    Storm     
 3,604,931  A  9/1971    Kastner et al.     
 3,640,787  A  2/1972    Heller     
 3,689,949  A  9/1972    Weinstein et al.     
 3,707,734  A  1/1973    Matthews     
 3,745,998  A  7/1973    Rose     
 3,762,404  A  10/1973    Sakita     
 3,778,049  A  12/1973    Viamonte, Jr.     
 3,783,251  A  1/1974    Pavkovich     
 3,848,132  A  11/1974    Foderaro     
 3,851,644  A  12/1974    Slagle     
 3,852,610  A  12/1974    McIntyre     
 3,885,258  A  5/1975    Regan     
 3,893,198  A  7/1975    Blair     
 3,897,345  A  7/1975    Foster     
 3,897,777  A  8/1975    Morrison     
 3,901,588  A  8/1975    Longhenry     
 3,905,054  A  9/1975    Windsor et al.     
 3,942,012  A  3/1976    Boux     
 3,947,686  A  3/1976    Cooper et al.     
 3,957,262  A  5/1976    McReynolds     
 3,986,697  A  10/1976    Amor, Jr. et al.     
 4,030,719  A  6/1977    Gabriele et al.     
 4,034,224  A  7/1977    Heavens et al.     
 4,045,830  A  9/1977    Loeb et al.     
 4,064,401  A  12/1977    Marden     
 4,069,457  A  1/1978    Martin et al.     
 4,095,114  A  6/1978    Taumann     
 4,112,306  A  9/1978    Nunan     
 4,140,129  A  2/1979    Heinz et al.     
 4,146,793  A  3/1979    Bergstrom et al.     
 4,190,772  A  2/1980    Dinwiddie et al.     
 4,206,355  A  6/1980    Boux     
 4,230,129  A  10/1980    LeVeen     
 4,250,137  A*2/1981    Riedler 264/554
 4,252,594  A  2/1981    Cooper     
 4,256,112  A  3/1981    Kopf et al.     
 4,262,204  A  4/1981    Mirabella     
 4,269,512  A  5/1981    Nosler     
 4,287,425  A  9/1981    Elliott, Jr.     
 4,327,046  A  4/1982    Davis et al.     
 4,347,213  A  8/1982    Rogers, Jr.     
 4,378,813  A  4/1983    Lovelace et al.     
 4,392,239  A  7/1983    Wilkens     
 4,400,820  A  8/1983    O'Dell et al.     
 4,401,492  A*8/1983    Pfrommer 156/61
 4,442,352  A  4/1984    Brahme     
 4,450,122  A  5/1984    Gallina     
 4,484,571  A  11/1984    Velazquez     
 4,504,050  A  3/1985    Osborne     
 4,552,508  A  11/1985    Reid     
 4,578,757  A  3/1986    Stark     
 4,591,341  A  5/1986    Andrews     
 4,600,551  A*7/1986    Erb 264/222
 4,616,814  A  10/1986    Harwood-Nash et al.     
 4,628,523  A  12/1986    Heflin     
 4,666,304  A  5/1987    Davies     
 4,671,284  A  6/1987    Wilson et al.     
 4,672,212  A  6/1987    Brahme     
 4,682,818  A  7/1987    Morell     
 4,688,780  A  8/1987    Hanz     
 4,705,955  A  11/1987    Mileikowsky     
 4,752,064  A  6/1988    Voss     
 4,779,858  A  10/1988    Saussereau     
 4,789,930  A  12/1988    Sones et al.     
 4,796,613  A  1/1989    Heumann et al.     
 4,812,658  A  3/1989    Koehler     
 4,815,448  A  3/1989    Mills     
 4,819,257  A  4/1989    Grasser et al.     
 4,841,965  A  6/1989    Jacobs     
 4,848,340  A  7/1989    Bille et al.     
 4,870,287  A  9/1989    Cole et al.     
 4,905,267  A  2/1990    Miller et al.     
 4,907,251  A  3/1990    Mork et al.     
 4,912,787  A  4/1990    Bradcovich     
 4,917,344  A  4/1990    Prechter et al.     
 4,926,457  A  5/1990    Poehner et al.     
 4,979,519  A  12/1990    Chavarria et al.     
 5,014,290  A  5/1991    Moore et al.     
 5,017,789  A  5/1991    Young et al.     
 5,037,374  A  8/1991    Carol     
 5,039,057  A  8/1991    Prechter et al.     
 5,039,867  A  8/1991    Nishihara et al.     
 5,046,708  A  9/1991    Schaefer     
 5,048,071  A  9/1991    Van Steenburg     
 5,049,147  A  9/1991    Danon     
 5,054,049  A  10/1991    Manabe     
 5,079,426  A  1/1992    Antonuk et al.     
 5,081,665  A  1/1992    Kostich     
 5,090,047  A  2/1992    Angotti et al.     
 5,094,241  A  3/1992    Allen     
 5,107,839  A  4/1992    Houdek et al.     
 5,117,829  A  6/1992    Miller et al.     
 5,156,166  A  10/1992    Sebring     
 5,168,514  A  12/1992    Horton, Jr. et al.     
 5,207,688  A  5/1993    Carol     
 5,240,218  A  8/1993    Dye     
 5,242,455  A  9/1993    Skeens et al.     
 5,269,305  A  12/1993    Corol     
 5,274,864  A  1/1994    Morgan     
 5,276,927  A  1/1994    Day     
 5,278,886  A  1/1994    Kobiki et al.     
 5,281,232  A  1/1994    Hamilton et al.     
 5,287,576  A  2/1994    Fraser     
 5,343,048  A  8/1994    Pastyr     
 5,361,765  A  11/1994    Herlihy et al.     
 5,370,117  A  12/1994    McLaurin, Jr.     
 5,370,118  A  12/1994    Vij et al.     
 5,380,336  A  1/1995    Misko et al.     
 5,382,914  A  1/1995    Hamm et al.     
 5,388,580  A  2/1995    Sullivan et al.     
 5,402,463  A  3/1995    Umetani et al.     
 5,427,097  A  6/1995    Depp     
 5,446,548  A  8/1995    Gerig et al.     
 5,454,993  A  10/1995    Kostich     
 5,464,411  A  11/1995    Schulte et al.     
 5,485,502  A  1/1996    Hinton     
 5,485,833  A  1/1996    Dietz     
 5,511,549  A  4/1996    Legg et al.     
 5,531,229  A  7/1996    Dean et al.     
 5,538,494  A  7/1996    Matsuda     
 5,549,616  A  8/1996    Schulte     
 5,566,681  A  10/1996    Manwaring     
 5,570,409  A  10/1996    Yamaguchi et al.     
 5,588,430  A  12/1996    Bova et al.     
 5,595,191  A  1/1997    Kirk     
 5,596,619  A  1/1997    Carol     
 5,602,892  A  2/1997    Llacer     
 5,622,187  A  4/1997    Carol     
 5,675,851  A  10/1997    Feathers     
 5,676,673  A  10/1997    Ferre et al.     
 5,727,554  A  3/1998    Kalend et al.     
 5,730,745  A  3/1998    Schulte et al.     
 5,745,545  A  4/1998    Hughes     
 5,751,781  A  5/1998    Brown et al.     
 5,769,779  A  6/1998    Alderson     
 5,771,512  A  6/1998    Kurakake et al.     
 5,775,337  A  7/1998    Hauger et al.     
 5,778,047  A  7/1998    Mansfield et al.     
 5,782,244  A  7/1998    Kostich     
 5,792,147  A  8/1998    Evans et al.     
 5,797,924  A  8/1998    Schulte     
 5,800,352  A  9/1998    Ferre et al.     
 5,806,116  A  9/1998    Oliver et al.     
 5,820,444  A*10/1998    McGaughey 450/70
 5,820,553  A  10/1998    Hughes     
 5,823,192  A  10/1998    Kalend et al.     
 5,825,845  A  10/1998    Blair et al.     
 5,832,550  A  11/1998    Hauger et al.     
 5,847,403  A  12/1998    Hughes et al.     
 5,848,449  A  12/1998    Hauger et al.     
 5,851,182  A  12/1998    Sahadevan     
 5,865,832  A  2/1999    Knopp et al.     
 5,895,926  A  4/1999    Britton et al.     
 5,911,655  A  6/1999    Brenneisen     
 5,947,981  A  9/1999    Cosman     
 5,983,424  A  11/1999    Näslund     
 6,003,174  A  12/1999    Kantrowitz     
 6,023,694  A  2/2000    Kouchi et al.     
 6,026,392  A  2/2000    Kouchi et al.     
 6,085,227  A  7/2000    Edlund et al.     
 6,094,760  A  8/2000    Nonaka et al.     
 6,104,779  A  8/2000    Shepherd et al.     
 6,118,848  A  9/2000    Reiffel     
 6,161,237  A  12/2000    Tang et al.     
 6,178,430  B1  1/2001    Cohen et al.     
 6,195,578  B1  2/2001    Distler et al.     
 6,240,161  B1  5/2001    Siochi     
 6,269,499  B1  8/2001    Amir     
 6,275,564  B1  8/2001    Ein-Gal     
 6,279,579  B1  8/2001    Riaziat et al.     
 6,282,739  B1  9/2001    Livingston     
 6,308,353  B1  10/2001    Van Steenburg     
 6,316,776  B1  11/2001    Hiramoto et al.     
 6,325,758  B1  12/2001    Carol et al.     
 6,345,114  B1  2/2002    Mackie et al.     
 6,355,049  B1  3/2002    Gill     
 6,375,355  B1  4/2002    Fortin     
 6,376,846  B2  4/2002    Livingston     
 6,385,286  B1  5/2002    Fitchard et al.     
 6,405,072  B1  6/2002    Cosman     
 6,437,513  B1  8/2002    Stelzer et al.     
 6,445,766  B1  9/2002    Whitham     
 6,446,286  B1  9/2002    Karmalawy     
 6,452,999  B1  9/2002    Maida     
 6,462,490  B1  10/2002    Matsuda et al.     
 6,462,553  B1  10/2002    Badura     
 6,466,813  B1  10/2002    Shukla et al.     
 6,473,490  B1  10/2002    Siochi     
 6,476,403  B1  11/2002    Dolinskii et al.     
 6,565,577  B2  5/2003    Cosman     
 6,577,707  B2  6/2003    Siochi     
 6,597,005  B1  7/2003    Badura et al.     
 6,598,275  B1  7/2003    Kolody et al.     
 6,600,164  B1  7/2003    Badura et al.     
 6,614,038  B1  9/2003    Brand et al.     
 6,621,889  B1  9/2003    Mostafavi     
 6,639,234  B1  10/2003    Badura et al.     
 6,650,930  B2  11/2003    Ding     
 6,662,036  B2  12/2003    Cosman     
 6,665,555  B2  12/2003    Henderson     
 6,670,618  B1  12/2003    Hartmann et al.     
 6,677,597  B1  1/2004    Haberer et al.     
 6,683,318  B1  1/2004    Haberer et al.     
 6,690,965  B1  2/2004    Riaziat et al.     
 6,693,283  B2  2/2004    Eickhoff et al.     
 6,698,045  B1  3/2004    Coppens et al.     
 6,704,957  B2  3/2004    Rhodes     
 6,710,362  B2  3/2004    Kraft et al.     
 6,725,078  B2  4/2004    Bucholz et al.     
 6,730,921  B2  5/2004    Kraft     
 6,731,970  B2  5/2004    Schlossbauer et al.     
 6,736,831  B1  5/2004    Hartmann et al.     
 6,745,072  B1  6/2004    Badura et al.     
 6,754,299  B2  6/2004    Patch     
 6,757,355  B1  6/2004    Siochi     
 6,769,806  B2  8/2004    Moyers     
 6,774,383  B2  8/2004    Norimine et al.     
 6,777,700  B2  8/2004    Yanagisawa et al.     
 6,780,149  B1  8/2004    Schulte     
 6,792,078  B2  9/2004    Kato et al.     
 6,795,523  B2  9/2004    Steinberg     
 6,799,068  B1  9/2004    Hartmann et al.     
 6,803,591  B2  10/2004    Yamashita et al.     
 6,804,548  B2  10/2004    Takahashi et al.     
 6,809,325  B2  10/2004    Dahl et al.     
 6,813,788  B2  11/2004    Dinkler et al.     
 6,814,694  B1  11/2004    Pedroni     
 6,839,404  B2  1/2005    Clark et al.     
 6,855,942  B2  2/2005    Bechthold et al.     
 6,859,741  B2  2/2005    Haberer et al.     
 6,865,411  B2  3/2005    Erbel et al.     
 6,891,177  B1  5/2005    Kraft et al.     
 6,904,630  B2  6/2005    Al-Kassim et al.     
 7,011,447  B2  3/2006    Moyers     
 7,063,461  B2  6/2006    Coppens et al.     
 7,073,508  B2  7/2006    Moyers     
 7,076,821  B2  7/2006    DeMooy     
 7,120,223  B2  10/2006    Nafstadius     
 7,142,634  B2  11/2006    Engler et al.     
 7,154,108  B2  12/2006    Tadokoro et al.     
 7,154,991  B2  12/2006    Earnst et al.     
 7,173,265  B2  2/2007    Miller et al.     
 7,199,382  B2  4/2007    Rigney et al.     
 7,280,633  B2  10/2007    Cheng et al.     
 7,290,548  B2  11/2007    Ungemach et al.     
 7,301,162  B2  11/2007    Matsuda et al.     
 7,331,713  B2  2/2008    Moyers     
 7,348,579  B2  3/2008    Pedroni     
 7,372,053  B2  5/2008    Yamashita et al.     
 7,398,309  B2  7/2008    Baumann et al.     
 7,446,328  B2  11/2008    Rigney et al.     
 7,582,886  B2  9/2009    Trbojevic     
 7,587,024  B2  9/2009    Grözinger et al.     
 7,589,334  B2  9/2009    Hiramoto et al.     
 7,659,521  B2  2/2010    Pedroni     
 7,753,587  B2  7/2010    Kusch et al.     
 7,796,730  B2  9/2010    Marash et al.     
 7,847,275  B2  12/2010    Lifshitz et al.     
 7,984,715  B2  7/2011    Moyers     
 7,997,553  B2  8/2011    Sloan et al.     
 8,003,964  B2  8/2011    Stark et al.     
 8,083,408  B2  12/2011    Moyers     
 8,093,569  B2  1/2012    Miller et al.     
 8,100,132  B2  1/2012    Markstroem     
 8,129,699  B2  3/2012    Balakin     
 8,160,205  B2  4/2012    Saracen et al.     
 8,210,899  B2*7/2012    Bush 450/54
 8,373,143  B2  2/2013    Balakin     
 8,418,288  B2  4/2013    Miller et al.     
 8,479,743  B2  7/2013    Moyers     
 8,523,630  B2*9/2013    Bush 450/36
 8,567,405  B2  10/2013    Arn et al.     
 8,688,197  B2  4/2014    Balakin     
 2002//0027969  A1  3/2002    Maida     
 2002//0051513  A1  5/2002    Pugachev et al.     
 2002//0065461  A1  5/2002    Cosman     
 2002//0077545  A1  6/2002    Takahashi et al.     
 2002//0188194  A1  12/2002    Cosman     
 2002//0193685  A1  12/2002    Mate et al.     
 2003//0007601  A1  1/2003    Jaffray et al.     
 2003//0031301  A1  2/2003    Longton et al.     
 2003//0086527  A1  5/2003    Speiser et al.     
 2003//0095625  A1  5/2003    Steinberg     
 2003//0164459  A1  9/2003    Schardt et al.     
 2003//0183779  A1  10/2003    Norimine et al.     
 2004//0013414  A1  1/2004    Karger et al.     
 2004//0028188  A1  2/2004    Amann et al.     
 2004//0034438  A1  2/2004    Uematsu     
 2004//0034932  A1  2/2004    Zacharopoulos     
 2004//0042583  A1  3/2004    Wackerle et al.     
 2004//0082856  A1*4/2004    Marmarelis 600/437
 2004//0098804  A1  5/2004    Varadharajulu et al.     
 2004//0136495  A1  7/2004    Carlsson et al.     
 2004//0155206  A1  8/2004    Marchand et al.     
 2004//0158145  A1  8/2004    Ghelmansarai et al.     
 2004//0174958  A1  9/2004    Moriyama et al.     
 2004//0184579  A1  9/2004    Mihara et al.     
 2004//0184583  A1  9/2004    Nagamine et al.     
 2005//0116175  A1  6/2005    Haberer     
 2006//0002511  A1  1/2006    Miller et al.     
 2006//0183960  A1*8/2006    Sioshansi et al. 600/3
 2007//0093100  A1  4/2007    Sommer     
 2008//0005643  A1  1/2008    Park et al.     
 2008//0031414  A1  2/2008    Coppens     
 2008//0042076  A1  2/2008    Miller et al.     
 2008//0187097  A1  8/2008    Cheng et al.     
 2008//0192892  A1  8/2008    Dilmanian et al.     
 2009//0067577  A1  3/2009    Rigney et al.     
 2009//0154645  A1  6/2009    Lifshitz et al.     
 2009//0168960  A1  7/2009    Jongen et al.     
 2009//0202045  A1  8/2009    Guertin et al.     
 2009//0217456  A1  9/2009    Lempen et al.     
 2009//0260636  A1  10/2009    Markstroem     
 2009//0304153  A1  12/2009    Amelia et al.     
 2009//0309046  A1  12/2009    Balakin     
 2009//0314960  A1  12/2009    Balakin     
 2010//0162488  A1  7/2010    Dahlin et al.     
 2011//0185503  A1  8/2011    Yan     
 2012//0143051  A1  6/2012    Balakin     

 
 FOREIGN PATENT DOCUMENTS 
 
       DE       2 513 896                         10/1975      
       DE       2 833 800                         12/1979      
       DE       4 418 216                         11/1995      
       DE       196 12 091                         3/1997      
       DE       102 48 476                         9/2003      
       EP       0 019 136                         11/1980      
       EP       0 247 449                         12/1987      
       EP       0 283 082                         9/1988      
       EP       0 465 590                         1/1992      
       EP       0 986 070                         3/2000      
       EP       0 986 071                         3/2000      
       EP       1 064 881                         1/2001      
       EP       1 454 653                         9/2004      
       EP       1 584 353                         10/2005      
       EP       1 709 994                         1/2006      
       EP       1 792 595                         6/2007      
       EP       1 795 229                         6/2007      
       EP       1 900 392                         3/2008      
       EP       1 935 453                         6/2008      
       EP       2 368 600                         9/2011      
       EP       1 660 175                         2/2012      
       FR       2 701 391       A                8/1994      
       GB       0 870 225                         6/1961      
       GB       2 068 700                         8/1981      
       GB       2 213 066                         8/1989      
       JP       58-92905       U                6/1983      
       JP       58-152541       A                9/1983      
       JP       60-73506       U                5/1985      
       JP       61-194400                         8/1986      
       JP       07-204184                         8/1995      
       JP       7-299059       A                11/1995      
       NL       7309246                         10/1974      
       WO       WO 88/01848                         3/1988      
       WO       WO 90/11721                         10/1990      
       WO       WO 90/11723                         10/1990      
       WO       WO 94/08704                         4/1994      
       WO       WO 95/08293                         3/1995      
       WO       WO 99/10137                         3/1999      
       WO       WO 00/16175                         3/2000      
       WO       WO 00/59575                         10/2000      
       WO       WO 01/00276                         1/2001      
       WO       WO 01/89625                         11/2001      
       WO       WO 02/63638                         2/2002      
       WO       WO 03/039212                         5/2003      
       WO       WO 03/053520                         7/2003      
       WO       WO 03/076016                         9/2003      
       WO       WO 20/04/026401                         4/2004      
       WO       WO 20/04/032781                         4/2004      
       WO       WO 20/05/018734                         3/2005      
       WO       WO 20/05/018735                         3/2005      
       WO       WO 20/05/037167                         4/2005      
       WO       WO 20/05/102453                         11/2005      
       WO       WO 20/06/060886                         6/2006      
       WO       WO 20/06/076545                         7/2006      
       WO       WO 20/06/094533                         9/2006      
       WO       WO 20/07/054140                         5/2007      
       WO       WO 20/07/061426                         5/2007      
       WO       WO 20/07/062788                         6/2007      
       WO       WO 20/07/068066                         6/2007      
       WO       WO 20/07/127970                         11/2007      
       WO       WO 20/08/051358                         5/2008      
       WO       WO 20/08/064271                         5/2008      
       WO       WO 20/08/081480                         7/2008      
       WO       WO 20/08/142695                         11/2008      
       WO       WO 20/09/129847                         10/2009      
       WO       WO 20/09/142544                         11/2009      
       WO       WO 20/09/142545                         11/2009      
       WO       WO 20/09/142546                         11/2009      
       WO       WO 20/09/142548                         11/2009      
       WO       WO 20/09/142549                         11/2009      
       WO       WO 20/10/078048                         7/2010      
       WO       WO 20/11/094674                         8/2011      

 OTHER PUBLICATIONS
  
  Baglan, et al., “The Use of High-Dose-Rate Brachytherapy Alone After Lumpectomy in Patients With Early- Stage Breast Cancer Treated With Breast-Conserving Therapy” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 4, pp. 1003-1011, 2001.
  Baglan, et al.: “Accelerated Partial Breast Irradiation Using 3D Conformal Radiation Therapy (3D-CRT)”, n. Engl.J.Med., vol. 55, No. 2, pp. 302-311, 2003.
  Crile et al., “Factors Influencing Local Recurrence of Cancer After Partial Mastectomy” Cleveland Clinic Journal of Medicine, vol. 57, No. 2, pp. 143-146, Mar.-Apr. 1990.
  Dedicated Medical Ion Accelerator Design Study by Lawrence Berkeley Laboratory. et al., Dec. / 1977, PCTA008295-PCTA008455.
  Design of a Proton Therapy Synchrotron by Fermi National Accelerator Laboratory. Jun. 1986, LL467-LL574.
  Extended European Search Report for EP Application No. 07871543.0, mailed on May 4, 2012 in 9 pages.
  Fisher, et al., “Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer” N Engl. J. Med., vol. 347, No. 16, pp. 1233-1241, Oct. 17, 2002.
  Fisher, et al., “Conservative Surgery for the Management of Invasive and Noninvasive Carcinoma of the Breast: NSABP Trials” World J. Surg. 18, pp. 63-69, 1994.
  Fisher, et al., “Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol 6)” A Journal of American Cancer Society, vol. 57, No. 9, pp. 1717-1724, May 1, 1986.
  Formenti, et al., “T1 Stage Breast Cancer: Adjuvant Hypofractionated Conformal Radiation Therapy to Tumor Bed in Selected Postmenopausal Breast Cancer Patients-Pilot Feasibility Study” Radiation Oncology, vol. 222, No. 1, pp. 172-178, Jan. 2002.
  King, et al., “Long-Term Results of Wide-Field Brachytherapy as the Sole Method of Radiation Therapy after Segmental Mastectomy for Tis,1,2 Breast Cancer” The American Journal of Surgery, vol. 180, pp. 299-304, Oct. 2000.
  Krishnan, et al., “Breast Conservation Therapy With Tumor Bed Irradiation Alone With a Selected Group of Patients With Stage I Breast Cancer” The Breast Journal, vol. 7, No. 2, pp. 91-96, 2001.
  Liljegren, et al., “Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: Five-Year Results of a Randomized Triall” Journal of the National Cancer Institute, vol. 86, No. 9, pp. 717-722, May 4, 1994.
  Miller, Daniel W. “Review of Proton Beam Radiation Therapy” Medical Physics, vol. 22, No. 11, Pt. 2, pp. 1943-1954, Nov. 1995.
  Perera, et al. “Method of Localization and Implantation of the Lumpectomy Site for High Dose Rate Brachytherapy after Conservative Surgery for T1 and T2 Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 31, No. 4, pp. 959-965, 1995.
  Perera, et al. “Local Resection and Brachytherapy Connected to the Lumpectomy Site for Early Breast Cancer: A Pilot Study” Journal of Surgical Oncology, vol. 65, No. 4, pp. 263-268, Aug. 1997.
  Polgar, et al. “Sole Brachytherapy of the Tumor Bed After Conservative Surgery for T1 Breast Cancer: Five-Year Results of a Phase I-II Study and Initial Findings of a Randomized Phase III Trial” Journal of Surgical Oncology, vol. 80, Issue 3, pp. 121-128, Jul. 2002.
  Poti, et al., “Partial Breast Irradiation With Interstitial60 Co Brachytherapy Results in Frequent Grade 3 or 4 Toxicity. Evidence Based on a 12-Year Follow-Up of 70 Patients” Int. J. Radiation Oncology Biol. Phys., vol. 58, No. 4, pp. 1022-1033, 2004.
  Proton Therapy System by Brobeck Corporation, Nov. 1985, LL54413-LL54459.
  Schmidt-Ullrich, et al. “Breast Conservation Therapy for Early Stage Breast Carcinoma With Outstanding 10-Year Locoregional Control Rates: A Case for Aggressive Therapy to the Tumor Bearing Quadran” Int. J. Radiation Oncology Biol. Phys., vol. 27, pp. 545-552, ran Int. J. Radiation Oncology Biol. Phys., vol. 27, pp. 545-552, 1993.
  Urano, et al., “Ralative Biological Effectiveness of Modulated Proton Beams in Various Murine Tissues” Int. J. Radiation Oncology Biol. Phys., vol. 10, No. 4, pp. 509-514, 1984.
  Vaidya, et al. “Targeted Intra-Operative Radiotherapy (Targit): An Innovative Method of Treatment for Early Breast Cancer” Annals of Oncology, vol. 12, pp. 1075-1080, 2001.
  Veronesi, et al. “A Preliminary Report of Intraoperative Radiotherapy (IORT) in Limited-Stage Breast Cancers that are Conservatively Treated” European Journal of Cancer 37, pp. 2178-2183, 2001.
  Veronesi, et al. “Twenty-Year Follow-Up of a Randomized Study Comparing Breast-Conserving Surgery With Radical Mastectomy for Early Breast Cancer” N. Engl. J. Med., vol. 347, No. 16, pp. 1227-1232, Oct. 17, 2002.
  Vicini, et al. “Accelerated Treatment of Breast Cancer” Journal of Clinical Oncology, vol. 19, No. 7, pp. 1993-2001, Apr. 1, 2001.
  Wazer, et al., “Preliminary Results of a Phase I/II Study of HDR Brachytherapy Alone for T1/T2 Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 4, pp. 889-897, 2002.
  Wazer, et al., “Clinically Evident Fat Necrosis in Women Treated With High-Dose-Rate Brachytherapy Alone for Early-Stage Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 1, pp. 107-111, 2001.
  Whelan, et al. “Ipsilateral Breast Tumor Recurrence Postlumpectomy is Predictive of Subsequent Mortality: Results from a Randomized Trial” Int. J. Radiation Oncology Biol. Phys., vol. 30, pp. 11-16, 1994.
  Alpha Cradle, advertisement by Smithers Medical Products, Inc., received by Applicants in 1988.
  Bush, David: “A Technique of Partial Breast Irradiation Utilizing Proton Beam Radiotherapy Comparison with Conformal X-Ray Therapy,” Cancer Journal, Mar./Apr. 2007, vol. 13, Issue 2, pp. 114-118.
  Clark, et al.: “A Halo-ring Technique for Fractionated Stereotactic Radiotherapy”, The British Journal of Radiology, 1996, 66, 522-527.
  Hamilton, Russel J.: “Repositioning Accuracy of Non-Invasive Head Fixation System for Stereotectic Radiotherapy” MED-PHYS.23 (11). Nov. 1969, p. 1909-1917, XP000680957.
  Metcalfe et al., “Patient Immobiliation and Image Guidance,” The Physics of Radiotherapy X-Rays and Electrons, Capter 12: 2007, p. 727-764.
  Proceedings of a Medical Workshop on Accelerators for Charged-Particle Beam Therapy by Fermilab, Jan. 1985, LL33170-LL33313.
  Gill, et al.: “Relocatable Frame for Stereotactic External Beam Radiotherapy”, Int. J. Radiation Oncology, Biol. Phys. vol. 20, pp. 599-603, Mar. 1991.
  CBI Product Overview, CP-100 Robot Patient Positioner (www.bioinstruments.net/cp-100), color brochure downloaded from www.bioinstruments.net/cp-100 on Feb. 13, 2015, corresponding to brochure available for download as early as Aug. 2007.
 
 
     * cited by examiner
 
     Primary Examiner —Gloria Hale
     Art Unit — 3765
     Exemplary claim number — 1
 
(74)Attorney, Agent, or Firm — Knobbe Martens Olson & Bear LLP

(57)

Abstract

According to the improved systems and methods described herein, a patient may be immobilized so that one or both breasts are returned to a known position. Additionally, the improved systems and methods reduce respiratory movement of the breasts. Thus, the immobilization devices and techniques described herein provide accurate and reproducible breast positioning while simultaneously reducing respiratory motion.
17 Claims, 6 Drawing Sheets, and 8 Figures


INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

[0001] Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are incorporated by reference under 37 C.F.R. §1.57 and made a part of this specification. This application is a continuation of U.S. application Ser. No. 13/540,475, filed Jul. 2, 2012, which is a continuation of U.S. application Ser. No. 12/515,523, filed May 19, 2009, issued as U.S. Pat. No. 8,210,899 on Jul. 3, 2012, which is a national phase application of International Application No. PCT/US2007/085309, filed Nov. 20, 2007, designating the United States of America and published in the English language, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application No. 60/866,814, filed Nov. 21, 2006.

BACKGROUND OF THE INVENTION

[0002] 1. Field of the Invention
[0003] The present invention relates to devices and methods of immobilizing patients for radiation therapy.
[0004] 2. Description of the Related Art
[0005] Whole breast radiotherapy is a treatment that may follow local excision (lumpectomy) of invasive breast cancer. One rationale for adjuvant radiotherapy is to reduce the recurrence rate of the breast cancer by eliminating residual foci of cancer in the region of the primary tumor as well as presumed occult multicentric disease in remote areas of the breast. However, the majority of cancer recurrences in the same breast after breast radiation therapy are in the same quadrant as the initial tumor. In fact, some 80-90% of breast cancer recurrences after breast radiation therapy occur in the immediate vicinity of the lumpectomy scar. Accordingly, treatment directed more specifically at the region of the breast involved with cancer may be equally efficacious in minimizing breast recurrence.

SUMMARY OF THE INVENTION

[0006] Neither this summary nor the following detailed description purports to define the invention. The invention is defined by the claims.
[0007] In one embodiment, a method of forming a support structure for immobilizing a patient in a prone position for delivery of radiation to at least one breast of the patient comprises positioning a support brassier on the patient, the support brassier comprising a semi-rigid cup sized to engage a breast of the patient, positioning the patient in a prone position in a support structure so that the cup is proximate to, but not in contact with, a bottom surface of the support structure. The method further comprises placing a malleable substance around the cup so that the substance substantially occupies a space between the bottom surface of the support structure and the cup with the patient positioned in the support structure and hardening the malleable substance that is placed around the cup so that the malleable substance becomes a substantially rigid breast immobilization device comprising contours corresponding with the cup.
[0008] In one embodiment, a device for immobilizing a patient for delivery of radiation to a breast of the patient comprises a support structure for supporting a patient in a prone position and a breast immobilization device comprising contours that substantially define a negative relief image of a cup that is fitted over a breast of the patient, the breast immobilization device being positioned within the support structure so that the cup engages and is supported by the breast immobilization device.
[0009] In one embodiment, a method of immobilizing a patient for radiation therapy to the patient's chest comprises positioning a breast immobilization device within a support structure, the breast immobilization device comprising contours that are custom-fit to engage with at least one of a patient's breasts and positioning the patient in a prone position on the support structure so that the at least one breast engages with the contours of the support structure.
[0010] In one embodiment, a device for immobilizing a patient for delivery of radiation to a breast of the patient comprises means for supporting a patient in a prone position and means for immobilizing a breast of the patient during delivery of radiation to the breast, the immobilization means being supported by the supporting means, wherein the immobilization means is configured to reproducibly position the breast for each of a plurality of radiotherapy treatments.

BRIEF DESCRIPTION OF THE DRAWINGS

[0011] FIG. 1 is a side view of one embodiment of a radiation therapy system.
[0012] FIG. 2A is an isometric drawing of an exemplary patient support structure.
[0013] FIG. 2B is an isometric drawing of a breast immobilization device in the support structure of FIG. 2A, where the breast immobilization device is configured for immobilizing a left breast of a patient for radiation treatment.
[0014] FIG. 3A illustrates an exemplary support brassier that comprises a cup for supporting a breast that will receive radiation treatment.
[0015] FIG. 3B is a side view of an exemplary cup that may be used to support a breast.
[0016] FIG. 4 is a flowchart illustrating an exemplary method of fabricating a breast immobilization device and using the immobilization device in repeatedly immobilizing a patient for radiation therapy.
[0017] FIG. 5 is a flowchart illustrating an exemplary method of fabricating a breast immobilization device.
[0018] FIG. 6 is a flowchart illustrating an exemplary method of immobilizing a breast for radiation therapy.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Embodiments of the invention will now be described with reference to the accompanying Figures, wherein like numerals refer to like elements throughout The terminology used in the description presented herein is not intended to be interpreted in any limited or restrictive manner, simply because it is being utilized in conjunction with a detailed description of certain specific embodiments of the invention. Furthermore, embodiments of the invention may include several novel features, no single one of which is solely responsible for its desirable attributes or which is essential to practicing the inventions herein described.
[0020] FIG. 1 is a side view of one embodiment of a radiation therapy system 100. The exemplary radiation therapy system 100 is designed to deliver therapeutic radiation doses to a target region within a patient 108, such as a cancer patient 108, for treatment of malignant or other conditions from one or more angles or orientations with respect to the patient 108.
[0021] In one embodiment, the radiation therapy system 100 is designed to deliver therapeutic doses of proton beams to a target area within the patient. Additional details on the structure and operation of such a proton radiation system can be found in U.S. Pat. No. 4,870,287, titled MULTI-STATION PROTON BEAM THERAPY SYSTEM, which is incorporated herein in its entirety by reference. In other embodiments, the system 100 is designed to deliver any other clinically suitable form of radiation known in the art, such as, for example, x-rays, gamma rays, hadrons, neutrons, etc.
[0022] In certain embodiments, the radiation therapy system 100 may include a patient treatment station and a gantry 102 which includes a generally hemispherical or frustoconical support frame for attachment and support of other components of the radiation therapy system 100. Additional details on the structure and operation of the gantry 102 can be found in U.S. Pat. Nos. 4,917,344 and 5,039,057, both titled ROLLER-SUPPORTED, MODULAR, ISOCENTRIC GENTRY AND METHOD OF ASSEMBLY, which are each incorporated by reference in their entireties.
[0023] The exemplary system 100 also comprises a nozzle 110 which is attached and supported by the gantry 102 such that the nozzle 110 may revolve relatively precisely about a gantry isocenter 120. The system 100 comprises a radiation source 106 delivering a therapeutic beam, such as a beam of accelerated protons, which pass through and are shaped by an aperture positioned on a distal end of the nozzle 110. An exemplary beam path is represented by numeral 146. In one embodiment, the aperture may be adjusted according to a patient's particular prescription of therapeutic radiation therapy. In other embodiments, alternative gantry configuration may be used in order to direct a radiation beam towards the patient 108.
[0024] In the embodiment of FIG. 1, the system 100 also comprises one or more imagers 112 which, in this embodiment, are retractable with respect to the gantry 102 between an extended position and a retracted position. In the illustration of FIG. 1, the imager 112 is shown in the extended position. In one embodiment, the imager 112 comprises a solid-state amorphous silicon x-ray imager which can develop image information such as from incident x-ray radiation that has passed through a patient's body. The system 100 may also comprises an x-ray source configured to emit appropriate x-ray radiation which passes through interposed patient tissue so as to generate a radiographic image of the interposed materials via the imager 112. The retractable aspect of the imager 112 provides the advantage of withdrawing the imager screen from the beam path of the radiation source 106 when the imager 112 is not needed thereby providing additional clearance within the gantry 102 enclosure as well as placing the imager 112 out of the path of potentially harmful emissions from the radiation source 102 thereby reducing the need for shielding to be provided to the imager 112. In this embodiment, the imagers and radiation sources 130 are arranged orthogonally to provide radiographic images of the patient from two directions.
[0025] The exemplary system 100 also comprises a patient positioner 114 and a patient support structure 130, also referred to as a pod 130, attached to the patient positioner 114. In one embodiment, the patient positioner 114 is adapted to, upon receipt of appropriate movement commands, position the patient support structure 130 in multiple translational and rotational axes and may be capable of positioning the patient support structure 130 in three orthogonal translational axes (e.g., longitudinal, vertical, and lateral) as well as three orthogonal rotational axes (e.g., pitch, roll, and yaw) so as to provide a full six degrees freedom of motion to placement of the patient support structure 130. In the illustration of FIG. 1, a patient is positioned in a supine (face-up) position on the support structure 130.
[0026] In certain embodiments, such as will be described in further detail below, an immobilization device may be positioned in the support structure 130 and shaped to interface with the contours of a specific patient's body. Thus, in the embodiment of FIG. 1, an immobilization device may be inserted between the support structure 130 and the patient 108. In one embodiment, the immobilization device comprises one or more beanbags or foam bead cushions, such as the VAC-LOK™ foam bead cushions manufactured by Med-Tec, Inc. In another embodiment, the immobilization device comprises a two-part expandable foam, such as one or more foam products manufactured by Med-Tec, Inc, quick setting polymeric foam, or other suitable immobilization substances. In other embodiments, the immobilization device comprises pillows, cushions, and/or bean-bags, for example. The use of an immobilization device that is formed to engage the contours of a patients body may advantageously reduce the patient's movement, allowing the radiation treatment plan to reduce an amount of tissue surrounding a target area that is irradiated.
[0027] While the following description periodically refers to the patient positioning system 100, the improved devices and methods described herein are usable with various other patient positioning systems. For example, the devices and methods described herein are usable with other automatic, semi-automatic, manual controlled with direct interface to the positioner controller, or fully manual (e.g., releasing a brake and moving each device axis with a hand crank), positioning systems. Thus, the systems and methods discussed herein are suitable for use with any other radiotherapy treatment devices and facilities.
[0028] The radiation system 100 may be used to deliver radiation treatment to any portion of a patient, including a patient's breast or breasts. While the system 100 may be used to provide whole breast radiation to the patient, systems and methods that provide partial breast radiotherapy, thereby reducing the negative effects of radiation on the entire breast, may provide effective adjuvant radiotherapy to a cancer (or other treatment) region in a patient's breast, while minimizing recurrence of cancer in the treated breast. More particularly, by confining treatment to a limited volume of breast tissue adjacent to the treatment region of the breast, such as a lumpectomy cavity, the amount of normal tissue exposed to radiotherapy can be reduced, potentially reducing acute and chronic toxicity. In addition, the smaller target volumes may allow use of hypofractionated treatment schedules, which decrease the time and inconvenience of breast conservation therapy, possibly minimizing scheduling problems with systemic chemotherapy, and potentially improving outcome by reducing delay to local therapy. Partial-breast radiation therapy may include post-operative interstitial brachytherapy, intracavitary brachytherapy to lumpectomy cavity, and/or external beam radiotherapy with photons utilizing 3-D conformal techniques, for example, among other known or later developed techniques.
[0029] Proton therapy may possess characteristics that prove useful for performing partial breast irradiation. In comparison to three-dimensional conformal radiation therapy with x-rays, the inherently superior depth dose characteristics (Bragg peak) minimizes the integral dose delivered to surrounding normal tissues, particularly the lung, heart, chest wall and treatment breast. For example, the physical properties of proton beams allow precise beam stopping within tissue at any given depth and shape, which may allow a reduction in an integral dose delivered to normal tissues. Furthermore, this allows highly conformal doses to be delivered with a very uniform dose distribution, eliminating “hot spots” from within the treatment region. Additionally, proton therapy is non-invasive and does not require disruptions to the skin of the breast, which may lead to an improved cosmetic outcome. Accordingly, immobilization devices and methods described herein may be used in conjunction with proton therapy planning and delivery, as well as any other type of radiation planning and delivery devices.
[0030] As those of skill in the art will recognize, the level of immobilization of a patient and, more specifically, of a treatment region of the patient, is determined based at least partly on a size of the treatment region that is irradiated. For example, if a patient is completely immobilized so that there is no movement of the treatment region, irradiation may be targeted to only the treatment region without including any of the surrounding tissue in the treatment plan. Thus, an irradiation area in a partial breast treatment plan may be reduced through improved immobilization of the breast.
[0031] Depending on the patient, the breasts move from a little to a lot as the patient breaths. Accordingly, even if the treatment breast is immobilized, there is still a certain amount of movement of the breast due to movement of the patient's lungs caused by normal breathing. Accordingly, the treatment region of a breast may be further reduced if movement of the breasts can be reduced.
[0032] According to the improved systems and methods described herein, a patient may be immobilized so that a treatment breast is accurately returned to a known position for each radiotherapy treatment. Additionally, the improved systems and methods reduce respiratory movement of the breasts. Thus, the immobilization devices and techniques described herein provide accurate and reproducible breast positioning while simultaneously eliminating respiratory motion. By providing accurately repeatable breast positioning, as well as reduction in respiratory motion, the systems and methods described herein allow treatment of a reduced treatment region of the patient's breast.
[0033] FIG. 2A is an isometric drawing of an exemplary patient support structure 200 and FIG. 2B is an isometric drawing of a breast immobilization device 210 in the support structure 200, where the breast immobilization device 210 is configured for immobilizing a left breast of a patient for radiation treatment.
[0034] In the embodiment of FIGS. 2A and 2B the breast immobilization device 210 comprises two-part expandable foam that has been hardened around a portion of a patient in a prone (face-down) position. For example, the patient may be positioned in the support structure 200 with a slight gap between the breasts and a bottom surface 205 of the support structure 200. The two-part foam may then be poured, or otherwise placed, around the chest region of the patient and allowed to harden around the breasts so that the contours of the breasts are mirrored in negative relief in the hardened foam. Accordingly, the patient's breasts may be more fully supported by the contoured breast immobilization device 210 compared to only the support structure 200, for example. Additionally, because the immobilization device 210 is fitted with the patient in the prone position, respiratory movement of the treatment breast is minimized when compared to respiratory movement that is experienced when a patient is in the supine position. Thus, the breast immobilization device not only allows the patient to be reproducibly positioned within the support structure 200 using the custom-molded immobilization device 210, but the prone positioned patient exhibits less respiratory movement of the treatment breast.
[0035] In one embodiment, prior to forming the breast immobilization device 210, the patient's shoulders, abdomen, and/or pelvis are supported by pillows, beanbags, foam structures, such as foam bead vacuum cushions, and/or other support structures. In this embodiment, when the patient is properly positioned on the foam bead vacuum cushions, for example, an opening around the chest area is formed, which may be filled with two-part expandable foam, for example, in order to form the breast immobilization device 210. In one embodiment, the air may be removed from the vacuum cushions prior to placement of the two-part foam around the chest area, in order to provide a substantially rigid immobilization for the head, shoulder, abdomen, and/or pelvis areas, while leaving an open space between the breasts and the support surface 200. Thus, after formation of the immobilization device 210 around the patient's chest area, the support structure 200 is filled with one or more pillows, beanbags, or foam structures that support the legs, head, and arms of the patient while the chest area of the patient is supported by a breast immobilization device 210 comprising expandable foam, or like material. In one embodiment, the breast immobilization device 210 may be formed of one or more foam bead vacuum cushions or other materials that suitably conform to the contours of a patient's breast(s) and provide a rigid or semi-rigid support structure.
[0036] FIG. 3A illustrates an exemplary support brassier 300 that comprises a cup 310 for supporting a treatment breast of a radiotherapy patient. In one embodiment, the patient wears the support brassier 300 in order to further immobilize the treatment breast and/or repeatedly reposition the treatment breast in a substantially similar position. In one embodiment, the cup 310 is formed of rigid or semi-rigid material, such as plastic. In certain embodiments, the cup 310 may be replaced with other cups of various sizes in accordance with a breast size of the patient. For example, a series of cups may be interchangeably attached to the strap 330 so that cup sizes corresponding to varying breast sizes are available. In one embodiment, the cup 310 is configured to position the treatment breast in a reproducible shape. FIG. 3B is a side view of the exemplary cup 310.
[0037] In the embodiment of FIG. 3A, the support brassier 300 also comprises a compression material 320 that covers a breast that will not receive radiation treatment, which is referred to herein as the “contralateral breast.” Radiation treatment plans typically attempt to reduce radiation that is delivered to areas outside of the radiation treatment region, such as the contralateral breast that is not intended to receive radiation treatment. Thus, the compression material 320 advantageously compresses the contralateral breast and positions the compressed breast further from a path of the radiation beam that is delivered to the treatment breast that is positioned in the cup 310. In one embodiment, the compression material 320 comprises cloth that is sufficiently strong to significantly flatten the contralateral breast under the compression material 320 when the support brassier 300 is tightened around the patient. In certain embodiments, the support brassier 300 may comprise two support cups, such as cup 310, to support both breasts of a patient in reproducible positions. In other embodiments, the cup 310 may be removed from the brassier 300, such as in the illustration of FIG. 3B, and be coupled with the two-part foam so that the patient's treatment breast engages the cup only when two-part foam is adjacent the patient.
[0038] With reference again to FIG. 2B, the breast immobilization device 210 is shown with a breast contour 220 that corresponds with a shape of the cup 310. In this embodiment, the patient was fitted with a support brassier having a cup 310 over the left breast so that when the breast immobilization device 210 was formed, the shape of the cup 310 was mirrored in the immobilization device 210. As illustrated in FIG. 2B, at position 230 of the breast immobilization device 210 there is only a very shallow cavity in the immobilization device due to the compression material 320 that was placed over the patient's right breast. Thus, in the embodiment of FIG. 2B, the patient may be immobilized for radiation treatment to the left breast in a manner that is further described below.
[0039] FIG. 4 is a flowchart illustrating one embodiment of a method of fabricating a breast immobilization device and immobilizing a patient for partial breast radiation therapy. The exemplary method of FIG. 4 advantageously provides accurate and reproducible breast positioning while simultaneously reducing respiratory motion. The method of FIG. 4 may be used in conjunction with any type of radiation treatment, or other treatment to the breasts, such as full or partial breast radiation. Depending on the embodiment, the method of FIG. 4 may include fewer or additional blocks and the method may be performed in a different order.
[0040] Beginning in block 410, a support structure having contours customized for immobilization of a particular patient is fabricated, such as according to the method of FIG. 5, for example. The breast immobilization device, such as the immobilization device 210, may be fitted in a pod or other support structure that support other regions of the patient.
[0041] Continuing to block 420, a treatment plan is developed for delivering radiation therapy to the patient. The radiation may be any type available for treatment, such as x-ray or proton therapy, for example. The developed treatment plan may include full breast or partial breast treatments. In one embodiment, because the breast immobilization device 210 provides reproducible immobilization of the patient's breast, the efficiency of the radiation therapy may be increased. Accordingly, use of the breast immobilization device 210 in treatment planning may reduce the time required for the actual radiation delivery to a lumpectomy, or other treatment region. In addition, the improved immobilization of the patient's breast, and the reduction of movement normally caused by breathing that is realized by placing a patient in a prone position, allows the treatment plan to reduce a target area of the breast and reduce the amount of tissue peripheral to the treatment region that receives radiation.
[0042] In certain embodiments, three-dimensional multi-beam proton treatment plans are developed. In one embodiment, the treatment plan calls for three to four separate axial treatment beams that are utilized with various beam weightings. For example, a proton beam may be utilized for treatments with appropriate apertures, compensators and beam modulation. In one embodiment, beams are chosen to provide complete sparing of underlying cardiac and pulmonary tissue as well as avoiding the breast that is not targeted for treatment. Care may also be taken to provide adequate skin sparing.
[0043] Moving to block 430, the patient is immobilized for radiation treatment, such as according to the method of FIG. 6, for example. In one embodiment, the breast immobilization device fabricated in block 410, as well as a support structure in some embodiments, is used to reproducibly position the treatment breast in substantially the same position as when the treatment plan was developed. Because the breast immobilization device is solidified and formed to snugly engage the contours of the patients' breast (or the outer surface of a cup of the support brassiere), when the patient is positioned in the support structure the treatment breast is immobilized in substantially the same position as used when the breast immobilization device was fabricated. In embodiments where a support brassier is worn by the patient when the breast immobilization device is formed, the support brassier is again worn by the patient when the patient is immobilized for treatment.
[0044] Next, in block 440, radiation therapy, such as partial breast radiation therapy, is delivered to the patient. As noted above, any other type of radiation therapy may also be administered to the patient that is immobilized by the immobilization device.
[0045] Continuing to block 450, the administering physician, radiologist, or other personnel, determines if additional doses are to be delivered to the patient. In one embodiment, this determination is made primarily based on the predetermined treatment plan and may be made prior to fabrication of the immobilization device. For example, a radiation oncologist may prescribe a particular radiation dose on a periodic basis for a predetermined time period, such as every day for 2-6 weeks or once a week for several months. In some embodiments, the effects of the treatment are monitored and the treatment plan may be adjusted after certain radiotherapy treatments. If additional doses are to be applied, the method returns to block 430 where the patient is again immobilized and irradiation is applied to the immobilized breast (block 440). In one embodiment, the patient is fitted with the support brassiere, which may be reproducibly placed on the chest by utilizing applied skin marks. The patient may then be positioned in the breast immobilization device in a prone position on the support structure. In certain embodiments, orthogonal diagnostic quality x- rays are performed prior to each treatment and compared to digitally reconstructed radiographs to reproduce the body/breast position at the time of treatment planning CT scan. In certain embodiments, clips, such as titanium clips, which are placed at the periphery of the biopsy cavity or other anatomical locations may also be utilized for the alignment process.
[0046] Advantageously, the time period between sequential radiation treatments, and the associated immobilization of the patient, may vary significantly without affecting the reproducibility of immobilization that is obtained through using the breast immobilization device, and optionally the support brassier. For example, a patient treatment plan may call for daily, weekly, or monthly treatments. In any case, the patient is reproducibly immobilized using the breast immobilization device that is contoured to support the specific patient's breast in the prone position. As noted above, because the patient is placed in the prone position, the amount of breast movement caused by breathing may also be reduced, when compared to the amount of breast movement when in a supine position.
[0047] When no further treatment sessions are necessary, the method continues to block 450 where the treatment is complete.
[0048] FIG. 5 is a flowchart illustrating an exemplary method of fabricating a breast immobilization device, such as breast immobilization device 210. Depending on the embodiment, the method of FIG. 5 may include fewer or additional blocks and the blocks may be performed in a different order than is illustrated.
[0049] Beginning in block 510, the patient is fitted with a support brassier, such as the brassier illustrated in FIG. 3A and 38. In one embodiment, the support brassier comprises a rigid or semi-rigid cup that engages the treatment breast. The support brassier is configured so that the breasts may be repeatedly repositioned within the cup at substantially the same position. In some embodiments, a support brassier is not used in forming the immobilization device. In such an embodiment, a cup may be placed and/or held on the breast as the two-part foam is being poured around the breast and released prior to complete hardening of the two-part foam. In this embodiment, the cup may be part of the immobilization structure. In other embodiments, the patients skin may directly contact the two-part foam as the immobilization device is being formed.
[0050] Moving to block 520, the patient is positioned in a support structure, such as support structure 200 (FIG. 1), with a slight gap between the breasts and a bottom 205 of the pod 200. In other embodiments, however, the breasts may minimally contact the pod 200. If the breasts are compressed excessively, such as by having a portion of the patient's weight supported by the breasts compressed against the bottom of the pod 200, the breasts will be positioned closer to the patient's internal organs, such as heart and lungs. Additionally, accurate repositioning of the patient in a position where the breasts are compressed may be more difficult as the position of a particular breast region tends to vary from one compression of the breast to another. Accordingly, in an advantageous embodiment, the breasts are positioned with a small gap, or minimally contacting, the pod 200.
[0051] Continuing to block 530, the patient's shoulders, abdomen, and/or pelvis are supported by pillows, beanbags, foam structures, such as foam bead vacuum cushions, and/or other support structures, while leaving an area around the breasts temporarily directly unsupported. In this embodiment, the air may be removed from the vacuum cushions prior to placement of the two-part foam around the chest area (block 540), in order to provide a substantially rigid immobilization for the head, shoulder, abdomen, and/or pelvis areas. Thus, in certain embodiments the pod 200 is at least partially filled with one or more pillows, beanbags, foam structures, or similar materials. In certain embodiments, blocks 520 and 530 are performed concurrently, as the positioning of support structures around the patient aid in positioning of the patient's treatment breast in the appropriate positioned with respect to the pod 200.
[0052] Continuing to block 540, a two-part foam is poured around the chest region of the patient and allowed to harden around the breasts so that the contours of the breasts, or of the support brassier if used, are mirrored in negative relief in the hardened foam. More particularly, the two-part foam is initially malleable so that it may be poured around the chest of the patient and substantially fills the air spaces around the breasts (or brassiere). In one embodiment, the two-part form undergoes chemical changes that cause the foam to solidify. Accordingly, because the two-part form is placed around the breasts prior to solidifying, the foam will become a hardened mold of the patient's breasts, or of the support brassiere, when solidified in order to form the breast immobilization device. This breast immobilization device allows the breast to remain in a hanging position, rather than being compressed against a bottom surface of the pod 200. In one embodiment, rather than using two-part foam, the breast immobilization device may be formed of one or more foam bead vacuum cushion, or other materials that suitably conform to the contours of a patient's breast (and/or support brassiere) and provide a rigid or semi-rigid support structure.
[0053] FIG. 6 is a flowchart illustrating an exemplary method of immobilizing a breast for radiotherapy. As noted above, using the patient-specific breast immobilization device, a patient may be accurately and reproducibly positioned for delivery of radiation therapy, while simultaneously positioning the patient in a prone position so as to reduce respiratory motion. Depending on the embodiment, the method of FIG. 6 may include fewer or additional blocks and the blocks may be performed in a different order than is illustrated.
[0054] Beginning at block 610, the support brassier that was used to fabricate the breast immobilization device is repositioned on the patient. In one embodiment, the support brassiere is reproducibly placed on the chest of the patient utilizing applied skin marks. In other embodiments, other markers, such as small tattoos, for example, may be used to position the support brassier in substantially the same position on the patient as when the breast immobilization device was fabricated.
[0055] Moving to block 620, the patient is positioned in a prone position within the pod containing the breast immobilization device. In one embodiment, the patient lays on the pod containing the breast immobilization device so that the treatment breast is placed in the corresponding countour in the immobilization device. With the patient positioned on the pod, the pod may be moved to the radiation delivery area, such as within a gantry for radiotherapy.
[0056] The foregoing description details certain embodiments of the invention. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the invention can be practiced in many ways. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the invention should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the invention with which that terminology is associated. The scope of the invention should therefore be construed in accordance with the appended claims and any equivalents thereof.
(57)

Claims

1. A method of forming a support structure for immobilizing a patient in a prone position for delivery of radiation to at least one breast of the patient, the method comprising:
positioning a support brassiere on the patient, the support brassiere comprising a cup that is sized to engage a breast of the patient;
positioning the patient, who is wearing the support brassiere, in a prone position generally within a full-body support structure so that the cup of the support brassiere is suspended above an upward-facing surface of the full-body support structure;
with the patient positioned generally within the full-body support structure, introducing a malleable substance into a space between the upward-facing surface of the full-body support structure and the cup; and
hardening the malleable substance while it substantially occupies the space between the upward-facing surface of the full-body support structure and the cup so that the malleable substance becomes a substantially, rigid breast immobilization device configured to be supported by the full-body support structure, the substantially rigid breast immobilization device also configured to support and immobilize the cup.
2. The method of claim 1, wherein introducing a malleable substance comprises introducing a non-caustic foam into the space between the upward-facing surface of the full-body support structure and the cup.
3. The method of claim 1, wherein introducing a malleable substance comprises introducing a polymeric foam into the space between the upward-facing surface of the full-body support structure and the cup.
4. The method of claim 3, further comprising expanding the polymeric foam to substantially fill the space between the upward-facing surface of the full-body support structure and the cup.
5. The method of claim 1, wherein the malleable substance comprises a two-part expandable foam, and hardening the malleable substance comprises allowing the two parts of the foam to mix together.
6. The method of claim 1, wherein hardening the malleable substance forms a substantially rigid breast immobilization device comprising a top surface having a generally concave contour corresponding with an impression of the cup, and a bottom surface configured to engage with the upward-facing surface of the full-body support structure.
7. The method of claim 1, wherein hardening the malleable substance comprises forming a breast immobilization device comprising contours that are custom-fit to engage with the cup on at least one of the patient's breasts.
8. The method of claim 1, wherein positioning the patient in a prone position within the full-body support structure comprises supporting one or more of the patient's shoulders, abdomen, and pelvis with a pillow, beanbag, foam structure, and/or vacuum cushion positioned between the patient and the full-body support structure.
9. The method of claim 1, wherein the full-body support structure comprises lateral sides, and wherein introducing a malleable substance into a space between the upward-facing surface of the full-body support structure and the cup comprises containing the malleable substance within the lateral sides of the full-body support structure as the breast immobilization device is formed.
10. The method of claim 1, wherein the full-body support structure, the breast immobilization device, and the support brassiere are formed of substances that allow radiation to pass through them without substantial reflection or scattering of the radiation.
11. A method of forming a structure for supporting a patient in a prone position for delivery of radiation to at least one breast of the patient, the method comprising:
positioning the patient in a prone position generally within a full-body support structure, at least one breast of the patient suspended above an upward-facing surface of the full-body support structure;
with the patient positioned generally within the full-body support structure, pouring an expandable foam around the patient's chest region such that the foam substantially fills a space between the upward-facing surface of the full-body support structure and the at least one breast; and
hardening the expandable foam so that the contours of the at least one breast are mirrored in negative relief in the hardened foam, the hardened foam supported by the full-body support structure and also configured to support the at least one breast of the patient.
12. The method of claim 11, wherein the full-body support structure comprises lateral sides, and wherein pouring the expandable foam around the patient's chest region comprises containing the expandable foam within the lateral sides of the full-body support structure as the foam expands to substantially fill the space between the upward-facing surface of the full-body support structure and the at least one breast.
13. The method of claim 11, further comprising positioning a support brassiere on the patient before positioning the patient in the prone position, the support brassiere comprising a cup that is sized to engage the at least one breast of the patient.
14. The method of claim 13, wherein positioning the patient in the prone position comprises positioning the patient, who is wearing the support brassiere, in a prone position generally within the full-body support structure so that the cup of the support brassiere is suspended above the upward-facing surface of the full-body support structure.
15. The method of claim 14, wherein pouring the expandable foam comprises introducing the foam into a space between the upward-facing surface of the full-body support structure and the cup of the support brassiere.
16. The method of claim 11, wherein the expandable foam comprises a two-part foam, and wherein hardening the expandable foam comprises allowing the two parts of the foam to mix together.
17. The method of claim 11, wherein the expandable foam comprises a non-caustic, polymeric foam.
*****

Download Citation


Sign in to the Lens

Feedback